Named on one round in the feed.
Since 2025-03-26
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Supira Medical Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional heart procedures. | Series E Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-03-26 | [ PART ] |
No sector on record.